Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hossein Jadvar

Showing results (21-30 of 162) with videos related to

Pageof 17
Sort By:
Diagnostics (Basel, Switzerland)|July 21, 2017
The Use of Imaging in the Prediction and Assessment of Cancer Treatment ToxicityHossein Jadvar
Clinical and Translational Imaging|July 18, 2017
Multimodal Imaging in Focal Therapy Planning and Assessment in Primary Prostate CancerHossein Jadvar
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 22, 2018
Oligometastatic Prostate Cancer: Molecular Imaging and Clinical Management Implications in the Era of Precision OncologyHossein Jadvar
AJR. American Journal of Roentgenology|May 3, 2017
Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer TreatmentHossein Jadvar
Molecular Imaging|April 29, 2009
Molecular imaging of prostate cancer: a concise synopsisHossein Jadvar
Seminars in Nuclear Medicine|June 12, 2012
Hepatocellular carcinoma and gastroenteropancreatic neuroendocrine tumors: potential role of other positron emission tomography radiotracersHossein Jadvar
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2018
SNMMI Scientific Delegation to CubaHossein Jadvar
Radiology|May 24, 2022
Prostate-specific Membrane Antigen PET: Standard Imaging in Prostate CancerHossein Jadvar
European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2018
Value proposition of PSMA-targeted α-particle radioligand therapy in metastatic prostate cancerHossein Jadvar
Radiology|March 31, 2021
Competitive Advantage of PSMA Theranostics in Prostate CancerHossein Jadvar
Pageof 17

Showing results (21-30 of 162) with videos related to

Sort By:
Pageof 17
Diagnostics (Basel, Switzerland)|July 21, 2017
The Use of Imaging in the Prediction and Assessment of Cancer Treatment ToxicityHossein Jadvar
Clinical and Translational Imaging|July 18, 2017
Multimodal Imaging in Focal Therapy Planning and Assessment in Primary Prostate CancerHossein Jadvar
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 22, 2018
Oligometastatic Prostate Cancer: Molecular Imaging and Clinical Management Implications in the Era of Precision OncologyHossein Jadvar
AJR. American Journal of Roentgenology|May 3, 2017
Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer TreatmentHossein Jadvar
Molecular Imaging|April 29, 2009
Molecular imaging of prostate cancer: a concise synopsisHossein Jadvar
Seminars in Nuclear Medicine|June 12, 2012
Hepatocellular carcinoma and gastroenteropancreatic neuroendocrine tumors: potential role of other positron emission tomography radiotracersHossein Jadvar
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2018
SNMMI Scientific Delegation to CubaHossein Jadvar
Radiology|May 24, 2022
Prostate-specific Membrane Antigen PET: Standard Imaging in Prostate CancerHossein Jadvar
European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2018
Value proposition of PSMA-targeted α-particle radioligand therapy in metastatic prostate cancerHossein Jadvar
Radiology|March 31, 2021
Competitive Advantage of PSMA Theranostics in Prostate CancerHossein Jadvar
Pageof 17